Key result
Baseline moderate-to-severe depression linked to ~43% lower odds of 1-year smoking abstinence.
Why the study?
Depression may make smoking cessation more difficult and cessation may affect depression symptoms, but these associations require further assessment.
Does baseline depression predict 1-year smoking abstinence, and does abstinence improve depression symptoms in patients attending a smoking cessation clinic?
Observational (n=3,775)
No
Does baseline depression predict 1-year smoking abstinence, and does abstinence improve depression symptoms in patients attending a smoking cessation clinic?
Answers are grounded in this paper and cite their sources.
Baseline depression reduces the likelihood of successful smoking cessation, but patients who successfully quit experience significant improvements in depressive symptoms.
Smoking is more prevalent among people with depression. Depression may make cessation more difficult and cessation may affect depression symptoms. The aims of this study were to assess the associations between (1) baseline depression and 1-year smoking abstinence and (2) abstinence and change in depression. Observational study using data collected routinely in a smoking cessation clinic in the Czech Republic from 2008 to 2014. Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck's Depression Inventory (BDI-II). Logistic regressions assessed if depression level predicted 1-year biochemically verified abstinence while adjusting for patient and treatment characteristics. Aim 2: N = 835 patients abstinent at 1 year; change in depression was analysed using Chi-square statistics, t test and mixed method analyses of variance. Rate of abstinence was lower for patients with mild (32.5%, OR = 0.68; 95% CI: 0.54 to 0.87, p = 0.002) and moderate/severe depression (25.8%; OR = 0.57, 95% CI: 0.45 to 0.74, p < 0.001) compared with patients without depression (40.5%). Across abstinent patients, the majority with baseline depression reported lower depression levels at follow-up. Overall mean (SD) BDI-II scores improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. There were significant main effects of time (F(1832) = 880.8, p < 0.001, partial η2 = 0.51) and baseline depression level (F(2832) = 666.4, p < 0.001, partial η2 = 0.62) on follow-up depression and a significant depression * time interaction (F(2832) = 296.5, p < 0.001, partial η2 = 0.42). In this effective smoking cessation clinic, depression at the start of treatment predicted reduced smoking abstinence 1 year later. Patients abstinent from smoking experienced considerable improvement in depression.
No takes yet. Share an insight, caveat, or question.
Štěpánková et al. (2016) conducted an observational in Smoking and Depression (n=3,775). Baseline depression (moderate/severe) vs. No depression was evaluated on 1-year biochemically verified abstinence (OR 0.57, 95% CI 0.45 to 0.74, p=< 0.001). Baseline moderate/severe depression was associated with reduced 1-year smoking abstinence compared to no depression.
Synapse has enriched 10 related papers. Consider them for comparative context: